Patch testing in adverse drug reactions

Contact Dermatitis (Fifth Edition)

Volumn , Issue , 2011, Pages 475-491

  Gonçalo, Margarida ^a   Bruynzeel, Derk P ^b  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892296030     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-03827-3_26     Document Type: Chapter

References (129)

1. Bruynzeel D, Maibach H (1998) Patch testing in systemic drug eruptions. In: Kaupinen K, Alanko K, Hannuksela M, Maibach H (eds) Skin reactions to drugs. CRC, Boca Raton, pp 97-109.
2. Roujeau J (1997) Drug induced skin reactions. In: Grobb JJ, Stern RS, Mac Kie RM, Weinstock WA (eds) Epidemiology, causes and prevention of skin diseases. Blackwell, Oxford.
3. Bigby M (2001) Rates of cutaneous reactions to drugs. Arch Dermatol 137:765-770.
4. Fiszenson-Alabala F, Auzerie V, Mahe E et al (2003) A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol 149:1018-1022.
5. Roujeau J (2005) Clinical heterogeneity of drug hypersensitivity. Toxicology 209:123-129.
6. Lacouture M, Melosky D (2007) Cutaneous reactions to anticancer agents targeting the epidermal growth factor receptor: A dermatology - oncology perspective. Skin Therapy Lett 12:1-5.
7. Friedmann P (2003) Mechanisms in cutaneous drug hypersensitivity. Clin Exp Allergy 33:861-872.
8. Halevy S (2009) Acute generalized exanthematous pustulosis. Curr Opin Allergy Clin Immunol 9:322-328.
9. Gonçalo M, Bruynzeel D (2008) Mechanisms in cutaneous drug hypersensitivity reactions. In: Marzulli FN, Maibach HI (eds) Dermatotoxicology, 7th edn. CRC, Boca Raton, pp 259-268.
10. Gonçalo M, Oliveira H, Monteiro C et al (1999) Allergic and systemic contact dermatitis from estradiol. Contact Derm 40:58-59.
11. Veien N, Menné T, Maibach H (2008) Systemic contacttype dermatitis. In: Marzulli FN, Maibach HI (eds) Dermatotoxicology, 7th edn. CRC, Boca Raton, pp 139-153.
12. Hausermann P, Harr T, Bircher A (2004) Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome? Contact Derm 51:297-310.
13. Lammintausta K, KorteKangas-Savolainen O (2005) The usefulness of skin tests to prove drug hypersensitivity. Br J Dermatol 152:968-974.
14. Barbaud A (2005) Drug patch testing in systemic cutaneous drug allergy. Toxicology 209:209-216.
15. Barbaud A, Gonçalo M, Bircher A, Bruynzeel D (2001) Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Derm 45:321-328.
16. Bruynzeel D, Von Blomberg-Van der Flier M, Scheper R et al (1985) Allergy for penicillin and the relevance of epicutaneous tests. Dermatologica 171:429-434.
17. Elzagallaai A, Knowles S, Rieder M et al (2009) Patch testing in the diagnosis of anticonvulsivant hypersensitivity syndrome. A systematic review. Drug Safety 32:391-408.
18. Phillips E, Mallal S (2009) HLA and drug-induced toxicity. Curr Opin Mol Ther 11:231-242.
19. Phillips E, Mallal S (2009) Successful translation of pharmacogenetics into the clinic: The abacavir example. Mol Diagn Ther 13:1-9.
20. Blanca M, Romano A, Torres M et al (2009) Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 64:183-193.
21. Hari Y, Frutig-Schnyder K, Hurni M et al (2001) Tcell involvement in cutaneous drug eruptions. Clin Exp Allergy 31:1398-1408.
22. Pichler W (2003) Delayed drug hypersensitivity reactions. Ann Intern Med 139:683-693.
23. Pichler W, Tilch J (2004) The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 59:809-820.
24. Bircher A (1999) Drug-induced urticaria and angioedema caused by non-IgE mediated pathomechanisms. Eur J Dermatol 9:657-663.
25. Yawalkar N, Hari Y, Frutig K et al (2000) T cells isolated from positive epicutaneous test reactions to amoxicillin and ceftriaxone are drug specific and cytotoxic. J Invest Dermatol 115:647-652.
26. Britschgi M, Steiner U, Schmid S et al (2001) T-cell involvement in drug-induced acute generalized exanthematic pustulosis. J Clin Invest 107:1433-1441.
27. Kuechler P, Britschgi M, Schmid S et al (2004) Cytotoxic mechanisms in different forms of T-cell-mediated drug allergies. Allergy 59:613-622.
28. Naisbitt D (2004) Drug hypersensitivity reactions in the skin: understanding mechanisms and the development of diagnostic and predictive tests. Toxicology 194: 179-196.
29. Pichler W (2002) Pharmacological interactions of drugs with antigen-specific immune receptors: The p-i concept. Curr Opin Allergy Clin Immunol 2:301-305.
30. Schmid D, Depta J, Pichler W (2006) T cell-mediated hypersensitivity to quinolones: mechanisms and crossreactivity. Clin Exp Allergy 36:59-69.
31. Posadas S, Pichler W (2007) Delayed drug hypersensitivity reactions: new concepts. Clin Exp Allergy 7:898-999.
32. Choquet-Kastylevsky G, Intrator L, Chenal C et al (1998) Increased levels of interleukin-5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome. Br J Dermatol 139:1026-1032.
33. Kardaun S, Sidoroff A, Valleyrie-Allanore L et al (2007) Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 156:609-612.
34. Britschgi M, Pichler W (2002) Acute generalized exanthematous pustulosis. Role of cytotoxic T cells in pustule formation: A clue to neutrophil-mediated processes orchestrated by T cells. Curr Opin Allergy Clin Immunol 2: 325-331.
35. Thomas E, Bellón T, Barranco P et al (2008) Acute generalized exanthematous pustulosis due to tetrazepam. J Investig Allergol Clin Immunol 18:119.
36. Nassif A, Bensussan A, Boumsell L et al (2004) Toxic epidermal necrolysis: effector cells are drug specific cytotoxic T cells. J Allergy Clin Immunol 114:1209-1215.
37. Nassif A, Moslehi H, Le Gouvello S et al (2004) Evaluation of the potential role of cytokines in toxic epidermal necrolysis. J Invest Dermatol 123:850-855.
38. Shiohara T, Mizukawa Y, Teraki Y (2002) Pathophysiology of fixed drug eruption: The role of skin-resident T cells. Curr Opin Allergy Clin Immunol 2:317-323.
39. Mizukawa Y, Yamazaki Y, Shiohara T (2008) In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption. Br J Dermatol 158:1230-1238.
40. Gonçalo M, Figueiredo A, Tavares P et al (1992) Photosensitivity to piroxicam: Absence of cross reaction with tenoxicam. Contact Derm 27:287-290.
41. Gonçalo M (1998) Exploration dans les photo-allergies médicamenteuses. In: GERDA. Progrès en Dermato- Allergologie. John Libbey Eurotext, Nancy, pp 67-74.
42. Oliveira H, Gonçalo M, Figueiredo A (1996) Photosensitivity from lomefloxacine. A clinical and photobiological study. Photoderm Photoimmunol Photomed 16:116-120.
43. Griem P, Wulferink M, Sachs B et al (1998) Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunol Today 19:133-141.
44. Moore N, Biour M, Paux G et al (1985) Adverse drug reaction monitoring: doing it the French way. Lancet 9:1056-1058.
45. Lammintausta K, KorteKangas-Savolainen O (2005) Oral challenge in suspected cutaneous adverse drug reactions. Acta Derm Venerol 85:491-496.
46. Alanko K, Kaupinnen K (1998) Diagnosis of drug eruptions: clinical evaluation and drug challenge. In: Kauppinen K, Alanko K, Hannuksela M, Maibach H (eds) Skin reactions to drugs. CRC, Boca Raton, pp 75-79.
47. Merk H (2005) Diagnosis of drug hypersensitivity: lymphocyte transformation test and cytokines. Toxicology 209: 217-220.
48. Hannuksela M (1998) Skin testing in drug hypersensitivity. In: Kauppinen K, Alanko K, Hannuksela M, Maibach H (eds) Skin reactions to drugs. CRC, Boca Raton.
49. Torres M, Sánchez-Sabaté E, Alvarez J et al (2004) Skin test evaluation in non-immediate allergic reactions to penicillins. Allergy 59:219-224.
50. Barbaud A, Tréchot P, Weber-Muller F et al (2004) Drug skin tests in cutaneous adverse drug reactions to prystinamycin: 29 cases with a study of cross-reactions between synergistins. Contact Derm 50:22-26.
51. Barbaud A, Reichert-Penetrat S, Tréchot P et al (1998) The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 139:49-58.
52. Osawa J, Naito S, Aihara M et al (1990) Evaluation of skin test reactions in patients with non-immediate type drug eruptions. J Dermatol 17:235-239.
53. Barbaud A (2002) Tests cutanés dans l'investigation des toxidermies: de la physiopathologie aux résultats des investigations. Thérapie 57:258-262.
54. Gonçalo M, Fernandes B, Oliveira H, Figueiredo A (2000) Epicutaneous patch testing in drug eruptions. Contact Derm 42:S22.
55. Barbaud A (2009) Skin testing in delayed reactions to drugs. Immunol Allergy Clin North Am 29:517-535.
56. Sidoroff A, Halevy S, Bavinck J et al (2001) Acute generalized exanthematous pustulosis (AGEP) - A clinical reaction pattern. J Cutan Pathol 28:113-119.
57. Buettiker U, Keller M, Pichler W et al (2006) Oral prednisolone induced acute generalized exanthematous pustulosis due to corticosteroids of group A confirmed by epicutaneous testing and lymphocyte transformation tests. Dermatology 213:40-43.
58. Schmid S, Kuechler P, Britschgi M et al (2002) Acute generalized exanthematous pustulosis. Role of cytotoxic T cells in pustule formation. Am J Pathology 161:2079-2086.
59. Gonçalo M, Figueiredo A, Poiares-Baptista A (1991) Pustulose exantemática aguda generalizada. Dois casos clínicos e revisão da literatura. Med Cut ILA 19:81-85.
60. Wolkenstein P, Chosidow O, Fléchet M et al (1996) Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Derm 35:234-236.
61. Serra D, Mariano A, Gonçalo M, Figueiredo A (2009) Acute exanthematic pustulosis, psoriasis and drugs. In Proceedings of 10th International Congress of Dermatology- ICD. Prague.
62. Hughes C, Foisy M, Dewhurst N et al (2008) Abacavir hypersensitivity reaction: An update. Ann Pharmacother 42:387-396.
63. Phillips E, Sullivan J, Knowles S, Shear N (2002) Utility of patch testing in patients with hypersensitivity syndromes associated with abacavir. AIDS 16:2223-2225.
64. Santiago F, Gonçalo M, Vieira R et al (2010) Epicutaneous patch testing in the diagnosis of drug hypersensitivity syndrome (DRESS). Contact Derm 62(1):47-53.
65. Santiago F, Gonçalo M, Brites M et al (2008) Drug hypersensitivity syndrome (DRESS): what patch tests can reveal us. Contact Derm 58:S17.
66. Gonçalo M, Oliveira H, Fernandes B et al (2002) Topical provocation in fixed drug eruption from nonsteroidal antiinflammatory drugs. Exogenous Dermatol 1:81-86.
67. Lee A (1998) Topical provocation in 31 cases of fixed drug eruption: change of causative drugs in 10 years. Contact Derm 38:258-260.
68. Alanko K (1994) Topical provocation of fixed drug eruption. A study of 30 patients. Contact Derm 31:25-27.
69. Robalo-Cordeiro M, Gonçalo M, Fernandes B et al (2000) Positive lesional patch tests in fixed drug eruptions from nimesulide. Contact Derm 43:307.
70. Oliveira H, Gonçalo M, Reis J, Figueiredo A (1999) Fixed drug eruption to piroxicam. Positive patch tests with crosssensitivity to tenoxicam. J Dermatolog Treat 10:209-212.
71. Devleeschouwer V, Roelandts R, Garmyn M, Goossens A (2008) Allergic and photoallergic contact dermatitis from ketoprofen: results of (photo) patch testing and follow-up of 42 patients. Contact Derm 58:159-166.
72. Asensio T, Sanchis M, Sánchez P, Vega J, Garcia J (2008) Photocontact dermatitis because of oral dexketoprofen. Contact Derm 58:59-60.
73. Serra D, Gonçalo M, Figueiredo A (2008) Two decades of cutaneous adverse drug reactions from piroxicam. Contact Derm 58:S35.
74. Vasconcelos C, Magina S, Quirino P, Barros M, Mesquita- Guimarães J (1997) Cutaneous drug reactions to piroxicam. Contact Derm 39:145.
75. Varela P, Amorim I, Massa A et al (1998) Piroxicam-betacyclodextrin and photosensitivity reactions. Contact Derm 38:229.
76. Youn J, Lee H, Yeo U, Lee Y (1993) Piroxicam photosensitivity associated with vesicular hand dermatitis. Clin Exp Dermatol 18:52-54.
77. Figueiredo A, Fontes Ribeiro C, Gonçalo S et al (1987) Piroxicam-induced photosensitivity. Contact Derm 17:73-79.
78. Hindsén M, Zimerson E, Bruze M (2006) Photoallergic contact dermatitis from ketoprofen in Southern Sweden. Contact Derm 54:150-157.
79. Kurumajin Y, Shono M (1992) Scarified photopatch testing in lomefloxacin photosensitivity. Contact Derm 26:5-10.
80. imura M, Kawada A (1998) Photosensitivity induced by lomefoxacin with cross-photosensitivity to ciprofloxacin and fleroxacin. Contact Derm 38:130.
81. Vilaplana J, Romaguera C, Azón A, Lecha M (1998) Flutamide photosensitivity-residual vitiliginous lesions. Contact Derm 38:68-70.
82. Martín-Lázaro J, Buján J, Arrondo A et al (2004) Is photopatch testing useful in the investigation of photosensitivity due to flutamide? Contact Derm 50:325-326.
83. Alanko K (1993) Patch testing in cutaneous reactions caused by carbamazepine. Contact Derm 29:254-247.
84. Camarasa J (1985) Patch test diagnosis of exfoliative dermatitis due to carbamazepine. Contact Derm 12:49.
85. Puig L, Nadal C, Fernández-Figueras M, Alomar A (1996) Carbamazepine-induced drug rashes: diagnostic value of patch tests depends on clinico-pathologic presentation. Contact Derm 34:435-437.
86. Silva R, Machado A, Brandão M, Gonçalo S (1982) Patch test diagnosis in carbamazepine erythroderma. Contact Derm 45:283-284.
87. Camarasa J, Serra-Baldrich E (1990) Tetrazepam allergy detected by patch test. Contact Derm 22:246.
88. Sánchez-Morillas L, Laguna-Martínez J, Reaño-Matos M et al (2008) Systemic dermatitis due to tetrazepam. J Investig Allergol Clin Immunol 18:404-406.
89. Pirker C, Misic A, Brinkmeier T, Frosch P (2002) Tetrazepam drug sensitivity - usefulness of the patch test. Contact Derm 47:135-138.
90. Shear N, Milpied B, Bruynzeel D, Phillips E (2009) A review of drug patch testing and implications for HIV clinicians. AIDS 22:999-1007.
91. Renn C, Straff W, DorfMüller A et al (2002) Amoxicillininduced rash in young adults with infectious mononucleosis: demonstration of drug specific reactivity. Br J Dermatol 147:1166-1170.
92. Gonzalo-Garijo M, Rodríguez-Nevado I, Argila D (2006) Patch tests for diagnosis of delayed hypersensitivity to cephalosporins. Allergol et Immunopathol 34:39-41.
93. Canelas M, Cardoso J, Gonçalo M, Figueiredo A (2008) Patch tests in the study of cutaneous drug reactions in erysipelas. Contact Derm 58:S18.
94. Seitz C, Bröcker E, Trautmann A (2009) Allergy diagnostic testing in clindamycin-induced skin reactions. Int Arch Allergy Immunol 149:246-250.
95. Lammintausta K, Tokola R, Kalimo K (2002) Cutaneous adverse reactions to clindamycin: results of skin testing and oral exposure. Br J Dermatol 146:643-648.
96. Gonzalo-Garijo M, Pérez Calderón R, Argila Fernandéz- Durán D, Rangel Mayoral J (2005) Cutaneous reactions due to diltiazem and cross reactivity with other calcium channel blockers. Allergol et Immunopathol 33:328-340.
97. Sousa-Basto A, Azenha A, Duarte M, Pardal-Oliveira F (1993) Generalized cutaneous reaction to diltiazem. Contact Derm 29:44-45.
98. Lachapelle J, Tennstedt D (1998) Les tests épicutanés dans les txidermies médicamenteuses. In: Progrès en Dermato- Allergologie. John Libbey Eurotext, Nancy, pp 57-66.
99. Scherer K, Tsakiris D, Bircher A (2008) Hypersensitivity reactions to anticoagulant drugs. Curr Pharm Des 14:2863-2873.
100. Koch P (2003) Delayed-type hypersensitivity skin reactions due to heparins and heparinoids. Tolerance of recombinant hirudins and of the new synthetic anticoagulant fondaparinux. Contact Derm 49:276-280.
101. Isaksson M, Persson L (1998) Contact allergy to hydrocortisone and systemic contact dermatitis from prednisolone with tolerance of betamethasone. Am J Contact Dermat 9:136-138.
102. Whitmore S (1995) Delayed systemic allergic reactions to corticosteroids. Contact Derm 32:193-198.
103. Beck M, Marot L, Nicolas J et al (2009) Allergic hypersensitivity to topical and systemic corticosteroids: A review. Allergy 64:978-994.
104. Barranco P, Rodríguez A, de Barrio M et al (2004) Sympathomimetic drug allergy: cross-reactivity study by patch test. Am J Clin Dermatol 5:351-355.
105. Dalmau J, Serra-Baldrich E, Roé E et al (2006) Skin reaction to hydroxyzine (Atarax): patch test utility. Contact Derm 54:216-217.
106. Ash S, Scheman A (1997) Systemic contact dermatitis to hydroxyzine. Am J Contact Dermat 8:2-5.
107. Bruynzeel D, Van Ketel W (1989) Patch testing in drug eruptions. Semin Dermatol 8:196-203.
108. Barbaud A, Tréchot P, Reichert-Penetrat S et al (2001) The usefulness of patch testing on the previously most severely affected site in a cutaneous adverse drug reaction to tetrazepam. Contact Derm 44:259-260.
109. Klein C, Trautmann A, Zillikens D, Bröcker E (1995) Patch testing in an unusual case of toxic epidermal necrolysis. Contact Derm 33:448-449.
110. Bruynzeel D, Ferguson J, Andersen K et al (2004) Photopatch testing: A consensus methodology for Europe. JEADV 18:679-682.
111. Cardoso J, Canelas M, Gonçalo M, Figueiredo A (2009) Photopatch testing with an extended series of photoallergens. A 5-year study. Contact Derm 60:314-319.
112. Gonçalo M, Coelho S, Figueiredo A (2006) Ascertaining patch test concentration in cutaneous adverse drug reactions to aminopenicillins and carbamazepine. J Invest Dermatol 126:S67.
113. Özkaya-Bayazit E, Bayazit H, Özmarmagan G (1999) Topical provocation in 27 cases of cotrimoxazole-induced fixed drug eruption. Contact Derm 41:185-189.
114. Barbaud A, Tréchot P, Reichert-Penetrat S et al (1999) Relevance of skin tests with drugs in investigating cutaneous adverse drug reactions. Contact Derm 45:265-268.
115. Verecken P, Birringer C, Knitelius A et al (1998) Sensitisation to benzyl alcohol: A possible cause of corticosteroid allergy. Contact Derm 38:106.
116. Shmunes E (1984) Allergic dermatitis to benzyl alcohol in an injectable solution. Arch Dermatol 120:1200-1201.
117. Schäfer T, Enders F, Przybilla B (1995) Sensitization to thimerosal and previous vaccination. Contact Derm 32: 114-116.
118. Mashiah J, Brenner S (2003) A systemic reaction to patch testing for the evaluation of acute generalized exanthematous pustulosis. Arch Dermatol 139:1181-1183.
119. Vaillant L, Camenen I, Lorette G (1989) Patch testing with carbamazepine: reinduction of an exfoliative dermatitis. Arch Dermatol 125:299.
120. Pietzcker F, Kuner V (1975) Anaphylaxie nach epicutanem Ampicillin-Test. Z Hautkr 50:437-440.
121. Maucher O (1972) Anaphylaktische Reaktionen beim Epicutantest. Hautartz 23:139-140.
122. Jonker M, Bruynzeel D (2003) Anaphylactic reaction by patch testing with diclofenac. Contact Derm 49:114-115.
123. Van Ketel W (1975) Patch testing in penicillin allergy. Contact Derm 1:253-254.
124. Barbaud A, Bene M, Schmutz J et al (1997) Role of delayed cellular hypersensitivity and adhesion molecules in maculopapular rashes induced by amoxycillin. Arch Dermatol 133:481-486.
125. Vieira R, Gonçalo M, Figueiredo A (2004) Patch testing with allopurinol and oxypurinol in drug eruptions. Contact Derm 50:156.
126. Schiavino D, Nucera E, de Pasquale T et al (2006) Delayed allergy to aminopenicillins: clinical and immunological findings. Int J Immunopathol Pharmacol 19:831-840.
127. Barbaud A, Girault P, Schmutz J et al (2009) No crossreactions between tetrazepam and other benzodiazepines: A possible chemical explanation. Contact Derm 61: 53-56.
128. Cravo M, Gonçalo M, Figueiredo A (2007) Fixed drug eruption to cetirizine with positive lesional patch tests to the three piperazine derivatives. Int J Dermatol 46:760-762.
129. LeCoz C, Bottleander A, Scrivener J et al (1998) Photocontact dermatitis from ketoprofen and tiaprofenic acid: cross-reactivity study in 12 consecutive patients. Contact Derm 38:245-252.